Clinical Trial Update: Phase 3 and Extensional Study of Besifovir [Phase 3]

View source ↗

Summary

Phase 3 trial update and extension study for Besifovir in chronic hepatitis B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Besifovir (besifovir)

Snippet

Sponsor: IlDong Pharmaceutical Co Ltd | Conditions: Chronic Hepatitis B | Phase 3 | Status: UNKNOWN